The Effect of Jazar Supplement on Quality of Life and Sexual Function in Postmenopausal Women: A Double-Blind, Randomized, Placebo-Controlled Trial

Table 4

A summary of changes in the vaginal pH and vaginal maturation index (VMI) during the trial period.

Subscales	Measurement points	Jazar (n = 43)	Placebo (n = 41)	value
Vaginal pH	Baseline	6.19 ± 1.07	6.24 ± 1.06	0.805
	Week 10	5.74 ± 0.82	6.49 ± 1.12	0.001
VMI	Baseline	39.63 ± 24.05	36.76 ± 23.30	0.057
	Week 10	44.46 ± 21.91	33.89 ± 21.82	0.030

The data are presented as mean (standard deviation). For comparison of the groups, an independent t-test was used.